| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 4.74352 | 35 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 4.91552 | 38 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 6.04398 | 59 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 4.91223 | 37 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 4.91755 | 38 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 4.46734 | 30 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 5.23736 | 45 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 4.35538 | 25 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 5.21156 | 44 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 4.6991 | 34 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 4.9143 | 39 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 5.18217 | 44 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 4.13005 | 20 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 4.93832 | 40 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 4.69678 | 35 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 4.95102 | 40 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 5.35424 | 48 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 5.55188 | 51 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 4.58673 | 31 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 7.54556 | 79 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 4.957 | 39 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 5.08039 | 42 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 4.87258 | 39 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 4.88645 | 38 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 4.5601 | 31 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 4.52151 | 31 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 5.4183 | 48 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 4.70324 | 33 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 4.53928 | 30 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 3.89596 | 12 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 4.21878 | 22 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 5.50143 | 50 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 4.59924 | 30 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 3.9669 | 15 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 4.78739 | 36 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 5.94796 | 57 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 4.35546 | 25 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 5.61287 | 51 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 4.56421 | 30 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 7.45754 | 75 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 5.15154 | 43 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 4.46957 | 28 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 5.48039 | 49 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 4.57201 | 32 |